Marion Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,934
Closed -$233K 162
2026
Q1
$233K Hold
1,934
0.05% 128
2025
Q4
$209K Buy
+1,934
New +$182K 0.05% 139
2025
Q2
Sell
-2,451
Closed -$220K 137
2025
Q1
$220K Sell
2,451
-23,480
-91% -$2.19M 0.06% 121
2024
Q4
$2.58M Buy
25,931
+1,592
+7% +$164K 0.68% 40
2024
Q3
$2.76M Buy
24,339
+1,346
+6% +$160K 0.74% 37
2024
Q2
$2.85M Buy
22,993
+286
+1% +$36.8K 0.84% 31
2024
Q1
$3M Sell
22,707
-115
-0.5% -$14.2K 0.89% 30
2023
Q4
$2.49M Buy
22,822
+1,257
+6% +$130K 0.8% 33
2023
Q3
$2.22M Sell
21,565
-932
-4% -$100K 0.78% 31
2023
Q2
$2.6M Buy
22,497
+381
+2% +$43.3K 0.92% 26
2023
Q1
$2.35M Buy
22,116
+578
+3% +$62.4K 0.88% 26
2022
Q4
$2.39M Buy
21,538
+3,366
+19% +$344K 1.01% 26
2022
Q3
$1.56M Buy
18,172
+1,027
+6% +$91.7K 0.8% 27
2022
Q2
$1.56M Buy
+17,145
New +$1.52M 0.82% 30

Other funds holding MRK

Marion Wealth Management's MRK Position: Q2 2026 in Review

Marion Wealth Management sold out of Merck (MRK) in Q2 2026, closing a stake of 1,934 shares — an estimated $233K sold.

Marion Wealth Management first reported a position in MRK in Q2 2022 and held it in 14 quarters. The position peaked at $3M in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Marion Wealth Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Marion Wealth Management sold 1,934 Merck shares in Q2 2026, an estimated $233K.
  • Marion Wealth Management first reported a position in Merck in Q2 2022 and held it in 14 quarters.
  • Marion Wealth Management's Merck position peaked at $3M in Q1 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Marion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.